1. Home
  2. CSGS vs AUPH Comparison

CSGS vs AUPH Comparison

Compare CSGS & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CSG Systems International Inc.

CSGS

CSG Systems International Inc.

N/A

Current Price

$80.07

Market Cap

2.3B

Sector

Technology

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$14.24

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CSGS
AUPH
Founded
1994
1993
Country
United States
Canada
Employees
N/A
128
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.9B
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CSGS
AUPH
Price
$80.07
$14.24
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$72.43
$17.25
AVG Volume (30 Days)
299.2K
973.0K
Earning Date
05-06-2026
05-11-2026
Dividend Yield
1.70%
N/A
EPS Growth
N/A
5075.00
EPS
1.98
2.07
Revenue
$996,810,000.00
$283,055,000.00
Revenue This Year
$5.45
$16.53
Revenue Next Year
$3.02
$16.24
P/E Ratio
$40.35
$6.75
Revenue Growth
13.91
20.38
52 Week Low
$54.65
$6.83
52 Week High
$80.67
$16.54

Technical Indicators

Market Signals
Indicator
CSGS
AUPH
Relative Strength Index (RSI) 55.56 47.76
Support Level $79.41 $13.52
Resistance Level $80.22 $15.23
Average True Range (ATR) 0.25 0.47
MACD 0.00 0.01
Stochastic Oscillator 57.65 28.32

Price Performance

Historical Comparison
CSGS
AUPH

About CSGS CSG Systems International Inc.

CSG Systems International Inc is a purpose-driven, SaaS platform company that enables companies in a wide variety of industry verticals to tackle the growing complexity of business in the digital age. The company's cloud-first architecture and customer-centric approach empower companies to deliver unforgettable experiences for B2B (business-to-business), B2C (business-to-consumer), and B2B2X (business-to-business-to-consumer) customers, making it easier for people and businesses to connect to, use and pay for the services the company offers. The company operates in one segment i.e. Solutions and Services. Geographically, it generates revenue from the United States.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: